TRCT
LNAI

Tower Research Capital (TRC)’s Lunai Bioworks LNAI Stock Holding History

Tower Research Capital (TRC)’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59K Buy
1,405
+817
+139% +$2.25K ﹤0.01% 4369
2026
Q1 		$1.92K Sell
588
-146
-20% -$725 ﹤0.01% 4580
2025
Q4 		$5.17K Buy
734
+31
+4% +$277 ﹤0.01% 4139
2025
Q3 		$7.99K Buy
703
+1
+0.1% +$19 ﹤0.01% 4069
2025
Q2 		$16.2K Buy
702
+501
+249% +$14K ﹤0.01% 3791
2025
Q1 		$8.73K Buy
201
+48
+31% +$3.07K ﹤0.01% 3856
2024
Q4 		$10.2K Sell
153
-54
-26% -$3.58K ﹤0.01% 3827
2024
Q3 		$7.99K Buy
+207
New +$14.4K ﹤0.01% 3991
2023
Q2 		– Sell
-132
Closed -$10K – 6311
2023
Q1 		$10K Buy
132
+36
+38% +$3.17K ﹤0.01% 4397
2022
Q4 		$8K Buy
96
+40
+71% +$5.37K ﹤0.01% 4446
2022
Q3 		$8K Sell
56
-22
-28% -$4.01K ﹤0.01% 4803
2022
Q2 		$12K Buy
78
+30
+63% +$13.7K ﹤0.01% 4300
2022
Q1 		$32K Sell
48
-77
-62% -$41K ﹤0.01% 3090
2021
Q4 		$73K Buy
+125
New +$90.8K ﹤0.01% 2459
2021
Q2 		– Sell
-41
Closed -$12K – 5779
2021
Q1 		$12K Sell
41
-38
-48% -$11.2K ﹤0.01% 4272
2020
Q4 		$19K Sell
79
-121
-61% -$30.6K ﹤0.01% 3904
2020
Q3 		$57K Buy
200
+157
+365% +$49.5K ﹤0.01% 3484
2020
Q2 		$15K Buy
+43
New +$13K ﹤0.01% 3824
2020
Q1 		– Sell
-96
Closed -$39K – 3753
2019
Q4 		$39K Buy
+96
New +$42.2K ﹤0.01% 1493
2019
Q3 		– Sell
-20
Closed -$8K – 4449
2019
Q2 		$8K Buy
+20
New +$9.75K ﹤0.01% 2706
2019
Q1 		– Hold
0
– – – 4193
2018
Q4 		– Hold
0
– – – 4263

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s LNAI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Lunai Bioworks (LNAI) stake by 139% in Q2 2026, buying an estimated $2.25K and bringing the position to 1,405 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #4369.

Tower Research Capital (TRC) first reported a position in LNAI in Q2 2019 and has held it in 20 quarters since. The position peaked at $73K in Q4 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Tower Research Capital (TRC) held 1,405 shares of Lunai Bioworks worth $4.59K as of Q2 2026.
  • Tower Research Capital (TRC) bought 817 Lunai Bioworks shares in Q2 2026, an estimated $2.25K.
  • Lunai Bioworks made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4369 holding.
  • Tower Research Capital (TRC) first reported a position in Lunai Bioworks in Q2 2019 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Lunai Bioworks position peaked at $73K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.